Preface |
|
viii | |
Exam Blueprints |
|
ix | |
Exam Content Outlines |
|
x | |
Contributors |
|
xi | |
Reviewers |
|
xii | |
Student Feedback |
|
xiii | |
|
1 Strategies for Studying and Test Taking |
|
|
1 | (6) |
|
|
|
1 | (1) |
|
Strategy 2 Know the Content to Be Studied |
|
|
1 | (1) |
|
Strategy 3 Know Your Strengths and Weaknesses |
|
|
1 | (1) |
|
Strategy 4 Develop a Study Plan |
|
|
1 | (1) |
|
Strategy 5 Get Down to the Business of Studying |
|
|
2 | (1) |
|
Strategy 6 Become Testwise |
|
|
3 | (1) |
|
Strategy 7 Apply Basic Rules of Standardized Test Taking |
|
|
4 | (1) |
|
Strategy 8 Psych Yourself Up |
|
|
5 | (1) |
|
|
5 | (1) |
|
|
6 | (1) |
|
2 Health Assessment and Diagnostic Tests |
|
|
7 | (26) |
|
|
|
7 | (2) |
|
|
9 | (8) |
|
Diagnostic Studies/Laboratory Tests |
|
|
17 | (8) |
|
|
25 | (1) |
|
|
26 | (3) |
|
|
29 | (2) |
|
|
31 | (2) |
|
|
33 | (98) |
|
|
|
|
Health Screening, Education, and Counseling: Risk Assessment, Disease Prevention, Counseling, and National Screening Guidelines |
|
|
33 | (9) |
|
|
42 | (8) |
|
Eye, Ear, Nose, and Throat Disorders |
|
|
50 | (7) |
|
Lower Respiratory Disorders |
|
|
57 | (4) |
|
Gastrointestinal Disorders |
|
|
61 | (10) |
|
|
71 | (4) |
|
|
75 | (3) |
|
|
78 | (5) |
|
|
83 | (7) |
|
Musculoskeletal Disorders |
|
|
90 | (6) |
|
|
96 | (2) |
|
|
98 | (6) |
|
|
104 | (8) |
|
|
112 | (8) |
|
|
120 | (7) |
|
|
127 | (4) |
|
4 Gynecologic, Reproductive, Sexual, and Menopause Health |
|
|
131 | (44) |
|
|
Female Reproductive Anatomy |
|
|
131 | (2) |
|
Female Reproductive Physiology |
|
|
133 | (3) |
|
Wellness Visits: The Reproductive Years |
|
|
136 | (2) |
|
|
138 | (19) |
|
|
157 | (1) |
|
|
158 | (7) |
|
|
165 | (5) |
|
|
170 | (4) |
|
|
174 | (1) |
|
5 Gynecologic, Reproductive, and Sexual Disorders |
|
|
175 | (48) |
|
|
|
|
Menstrual and Endocrine Disorders |
|
|
175 | (7) |
|
Benign and Malignant Tumors/Neoplasms |
|
|
182 | (2) |
|
|
184 | (4) |
|
|
188 | (3) |
|
Sexually Transmitted Infections |
|
|
191 | (8) |
|
|
199 | (2) |
|
Cervical Cancer Screening Abnormalities |
|
|
201 | (1) |
|
Diethylstilbestrol (DES) in Utero |
|
|
202 | (2) |
|
|
204 | (1) |
|
Pelvic Relaxation Disorders |
|
|
204 | (1) |
|
Toxic Shock Syndrome (TSS) |
|
|
205 | (1) |
|
|
206 | (1) |
|
|
207 | (1) |
|
Congenital and Chromosomal Abnormalities |
|
|
208 | (1) |
|
|
209 | (3) |
|
|
212 | (5) |
|
|
217 | (3) |
|
|
220 | (3) |
|
6 Prenatal Care and Assessment of Fetal Well-Being |
|
|
223 | (30) |
|
|
Human Reproduction and Fertilization |
|
|
223 | (1) |
|
Development of the Placenta, Membranes, and Amniotic Fluid |
|
|
223 | (2) |
|
Embryonic and Fetal Development |
|
|
225 | (1) |
|
Diagnosis and Dating of Pregnancy |
|
|
225 | (1) |
|
Maternal Physiologic Adaptations to Pregnancy |
|
|
226 | (2) |
|
Maternal Psychological/Social Changes in Pregnancy |
|
|
228 | (1) |
|
Overview of Antepartum Care |
|
|
229 | (1) |
|
|
230 | (3) |
|
Common Discomforts of Pregnancy and Comfort Measures |
|
|
233 | (2) |
|
Nutrition During Pregnancy |
|
|
235 | (1) |
|
The Childbearing Person and Their Family, and Their Role in Pregnancy |
|
|
235 | (1) |
|
|
236 | (1) |
|
Pharmacologic Considerations in the Antepartum Period |
|
|
237 | (1) |
|
Techniques Used to Assess Fetal Health |
|
|
238 | (8) |
|
Questions 240 Answers with Rationales |
|
|
246 | (4) |
|
|
250 | (3) |
|
7 High-Risk Pregnancy Care |
|
|
253 | (36) |
|
|
|
|
253 | (2) |
|
Intimate Partner Abuse/Violence Against Women (VAW) |
|
|
255 | (1) |
|
Infectious Disease in Pregnancy |
|
|
255 | (5) |
|
|
260 | (1) |
|
|
261 | (1) |
|
Blood Incompatibilities: D(Rh) Isoimmunization |
|
|
262 | (1) |
|
Post-Term Pregnancy (Postdates Pregnancy) |
|
|
263 | (1) |
|
|
263 | (1) |
|
Hyperemesis Gravidarum (HG) |
|
|
264 | (1) |
|
|
265 | (1) |
|
|
266 | (3) |
|
|
269 | (1) |
|
|
269 | (1) |
|
Gastroesophageal Reflux (GERD) in Pregnancy |
|
|
270 | (1) |
|
|
270 | (1) |
|
|
271 | (1) |
|
|
272 | (1) |
|
Hypertensive Disorders of Pregnancy |
|
|
273 | (1) |
|
|
274 | (1) |
|
|
275 | (1) |
|
|
275 | (1) |
|
Inherited Anemias: Hemoglobinopathies |
|
|
276 | (1) |
|
|
276 | (6) |
|
|
282 | (4) |
|
|
286 | (3) |
|
|
289 | (28) |
|
|
|
|
289 | (1) |
|
|
290 | (2) |
|
|
292 | (1) |
|
|
292 | (1) |
|
|
293 | (1) |
|
Management of the First Stage of Labor |
|
|
294 | (4) |
|
Management of the Second Stage of Labor |
|
|
298 | (1) |
|
|
299 | (2) |
|
Management of the Third Stage of Labor |
|
|
301 | (1) |
|
Management of Immediate Newborn Transition |
|
|
302 | (1) |
|
Special Considerations and Deviations from Normal |
|
|
302 | (5) |
|
|
307 | (6) |
|
|
313 | (2) |
|
|
315 | (2) |
|
9 Postpartum and Lactation |
|
|
317 | (16) |
|
|
|
317 | (1) |
|
Initial, Postpartum Period |
|
|
317 | (1) |
|
|
317 | (3) |
|
Postpartum Mental Health and Well-Being |
|
|
320 | (2) |
|
|
322 | (1) |
|
Postpartum Follow-Up Care |
|
|
322 | (2) |
|
|
324 | (1) |
|
|
325 | (2) |
|
|
327 | (3) |
|
|
330 | (2) |
|
|
332 | (1) |
|
10 Midwifery Care of the Newborn |
|
|
333 | (26) |
|
|
|
Physiologic Transition to Extrauterine Life |
|
|
333 | (1) |
|
Ongoing Extrauterine Transition |
|
|
334 | (1) |
|
Immediate Care and Assessment of the Healthy Newborn |
|
|
335 | (2) |
|
Care During the First Hours After Birth |
|
|
337 | (1) |
|
Plan of Care for the First Few Days of Life |
|
|
337 | (1) |
|
|
338 | (2) |
|
|
340 | (2) |
|
Primary Care of the Newborn for the First 6 Weeks |
|
|
342 | (2) |
|
Common Variations from Normal Newborn Findings |
|
|
344 | (1) |
|
|
345 | (6) |
|
|
351 | (4) |
|
|
355 | (2) |
|
|
357 | (2) |
|
11 Principles of Pharmacology |
|
|
359 | (14) |
|
|
|
Pharmacokinetics: The Study of How the Body Processes Drugs |
|
|
359 | (1) |
|
Pharmacodynamics: The Study of Mechanism of Drug Action on Living Tissue |
|
|
360 | (1) |
|
Pharmacogenomics: The Study of Genetic Variations That Influence Drug Metabolism and Drug |
|
|
|
|
360 | (1) |
|
Pharmacotherapeutic Indications |
|
|
360 | (1) |
|
|
361 | (7) |
|
|
368 | (2) |
|
|
370 | (1) |
|
|
371 | (2) |
|
12 Professional Practice Issues |
|
|
373 | (16) |
|
|
|
|
|
373 | (1) |
|
|
373 | (8) |
|
|
381 | (1) |
|
|
382 | (1) |
|
|
382 | (3) |
|
|
385 | (2) |
|
|
387 | (2) |
Index |
|
389 | |